Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Operating Leases (2022 - 2026)

Exagen filings provide 5 years of Operating Leases readings, the most recent being $111000.0 for Q1 2026.

  • On a quarterly basis, Operating Leases fell 91.89% to $111000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $111000.0, a 91.89% decrease, with the full-year FY2025 number at $438000.0, down 73.68% from a year prior.
  • Operating Leases hit $111000.0 in Q1 2026 for Exagen, down from $438000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $6.2 million in Q1 2022 to a low of $111000.0 in Q1 2026.
  • Median Operating Leases over the past 5 years was $2.5 million (2024), compared with a mean of $2.9 million.
  • Biggest five-year swings in Operating Leases: crashed 32.44% in 2023 and later plummeted 91.89% in 2026.
  • Exagen's Operating Leases stood at $4.5 million in 2022, then tumbled by 38.57% to $2.8 million in 2023, then tumbled by 39.71% to $1.7 million in 2024, then crashed by 73.68% to $438000.0 in 2025, then crashed by 74.66% to $111000.0 in 2026.
  • The last three reported values for Operating Leases were $111000.0 (Q1 2026), $438000.0 (Q4 2025), and $759000.0 (Q3 2025) per Business Quant data.